These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 476825)

  • 41. Bone-forming cell line derived from embryonal carcinoma cells.
    Nicolas JF; Gaillard J; Jakob H; Jacob F
    Nature; 1980 Aug; 286(5774):716-8. PubMed ID: 6931966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro.
    Martin GR; Evans MJ
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1441-5. PubMed ID: 1055416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The isolation and properties of a clonal tissue culture strain of pluripotent mouse teratoma cells.
    Evans MJ
    J Embryol Exp Morphol; 1972 Aug; 28(1):163-76. PubMed ID: 4672577
    [No Abstract]   [Full Text] [Related]  

  • 44. Susceptibility of teratocarcinoma cells to adenovirus type 2.
    Kelly F; Boccara M
    Nature; 1976 Jul; 262(5567):409-11. PubMed ID: 958395
    [No Abstract]   [Full Text] [Related]  

  • 45. Growth and differentiation of teratocarcinoma OTT6050 affected by host hormonal changes in old mice.
    Kubota K; Kubota R; Matsuzawa T
    Tohoku J Exp Med; 1987 Mar; 151(3):253-9. PubMed ID: 3590172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cleavage stage mouse embryos share a common cell adhesion system with teratocarcinoma cells.
    Ogou S; Okada TS; Takeichi M
    Dev Biol; 1982 Aug; 92(2):521-8. PubMed ID: 7117698
    [No Abstract]   [Full Text] [Related]  

  • 47. In vitro growth and differetiation of clonal populations of multipotential mouse clls derived from a transplantable testicular teratocarcinoma.
    Rosenthal MD; Wishnow RM; Sato GH
    J Natl Cancer Inst; 1970 May; 44(5):1001-14. PubMed ID: 4936569
    [No Abstract]   [Full Text] [Related]  

  • 48. Purification and characterization of a collagenous protein secreted by a murine teratocarcinoma-derived cell line.
    Ko CY; Priest RE
    Biochim Biophys Acta; 1982 Jun; 720(3):288-94. PubMed ID: 7104399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical markers of the progress of differentiation in cloned teratocarcinoma cell lines.
    Adamson ED; Evans MJ; Magrane GG
    Eur J Biochem; 1977 Oct; 79(2):607-15. PubMed ID: 72666
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neural differentiation in the OTT-6050 mouse teratoma. Production of a tumor fraction restricted to stem cells and neural cells after centrifugal elutriation.
    VandenBerg SR; Chatel M; Griffiths OM; DeArmond SJ; Pappas C; Herman MM
    Virchows Arch A Pathol Anat Histol; 1981; 392(3):281-94. PubMed ID: 7269228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neural differentiation in the OTT-6050 mouse teratoma: effects of intracerebral environment on the neural differentiation of embryoid bodies.
    DeArmond SJ; VandenBerg SR; Herman MM
    Virchows Arch A Pathol Anat Histol; 1981; 393(1):39-52. PubMed ID: 7347442
    [No Abstract]   [Full Text] [Related]  

  • 52. Development of experimental tumors formed by mouse and human embryonic stem and teratocarcinoma cells after subcutaneous and intraperitoneal transplantations into immunodeficient and immunocompetent mice.
    Gordeeva OF; Nikonova TM
    Cell Transplant; 2013; 22(10):1901-14. PubMed ID: 23051679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of E2F/cyclin A-containing complex upon retinoic acid-induced differentiation of teratocarcinoma cells.
    Reichel RR
    Gene Expr; 1992; 2(3):259-71. PubMed ID: 1450664
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PCC4azal teratocarcinoma stem cell differentiation in culture. I. Biochemical studies.
    Lo CW; Gilula NB
    Dev Biol; 1980 Mar; 75(1):78-92. PubMed ID: 7371997
    [No Abstract]   [Full Text] [Related]  

  • 55. Flow cytometric analysis of the effect 5-bromodeoxyuridine on mouse teratocarcinoma cells.
    Swartzendruber DE; Travis GL; Martin JC
    Cytometry; 1980 Nov; 1(3):238-44. PubMed ID: 7021106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
    Martin GM; Ogburn CE; Au K; Disteche CM
    J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytology of experimental teratomas and teratocarcinomas.
    Dominis M; Damjanov I; Solter D
    Experientia; 1975 Jan; 31(1):107-8. PubMed ID: 1112299
    [No Abstract]   [Full Text] [Related]  

  • 58. Multiangle light-scattering analysis of murine teratocarcinoma cells.
    Swartzendruber DE; Price BJ; Rall LB
    J Histochem Cytochem; 1979 Jan; 27(1):366-70. PubMed ID: 374600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidermal growth factor receptors increase during the differentiation of embryonal carcinoma cells.
    Rees AR; Adamson ED; Graham CF
    Nature; 1979 Sep; 281(5729):309-11. PubMed ID: 233127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protein synthesis inhibitors prevent the induction of laminin B1, collagen IV (alpha 1), and other differentiation-specific mRNAs by retinoic acid in F9 teratocarcinoma cells.
    Wang SY; Gudas LJ
    J Cell Physiol; 1988 Aug; 136(2):305-11. PubMed ID: 2842348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.